Neoplasia/BPH

	Parallel Liquid Biopsy Analysis of miR-371a-3p and Cell-Free DNA in an Unselected Cohort of Patients With Testicular Germ Cell Tumors. Andrology Matouskova L, Kralova R, Parobkova E, Bakardjieva-Mihaylova V, Zwyrtkova M, Kramarzova KS, Boublikova L. PMID: 42324838 [PubMed - as supplied by publisher]
	Preoperative Tumor-Informed ctDNA for Prediction of Nodal Metastases at Radical Cystectomy in Bladder Cancer. Ann Surg Oncol Aydogdu C, Wang B, McSweeney S, Pieretti A, Weight CJ, Autorino R, Kaouk J, Bukavina L. PMID: 42324366 [PubMed - as supplied by publisher]
	Radiomics analysis of CT imaging for predicting MIT family translocation renal cell carcinoma: a multicenter retrospective clinical study. BMC Cancer Lin SW, Wu XH, Liu WQ, Chen DN, Lin Y, Liu ZS, Wang JY, Yin HB, Xue XY, Xu N, Chen SH. PMID: 42323535 [PubMed - as supplied by publisher]
	Transcriptome-wide association studies implicate RCC1 and PHACTR4 in prostate cancer survival. Eur J Hum Genet Fu W, Rothstein JH, Melander O, Lilja H, Sieh W, Song X, Klein RJ. PMID: 42323493 [PubMed - as supplied by publisher]
	Nephroureterectomy with ileal cuff for upper tract recurrence after radical cystectomy: oncologic and survival outcomes. World J Urol Park IW, Uk PM, Lim B, Jeong IG, Suh J, Hong B. PMID: 42323467 [PubMed - indexed for MEDLINE]
	Efficacy and safety of darolutamide plus androgen-deprivation therapy in Black patients with metastatic hormone-sensitive prostate cancer from the phase 3 ARANOTE trial. Prostate Cancer Prostatic Dis Trinh QD, George DJ, Shore N, Vjaters E, Olmos D, de Santana Gomes AJP, de Andrade Mota AC, Littleton N, Srinivasan S, Verholen F, Haresh KP, Saad F. PMID: 42323390 [PubMed - as supplied by publisher]
	Automating standardization of prostate cancer biopsy and histopathology reports with privacy-preserving local large language models. Urol Oncol Malyala R, Namekawa T, Black A, Gleave M, Mannas M. PMID: 42322812 [PubMed - as supplied by publisher]
	Mortality in Castration Resistant Prostate Cancer Patients With and Without Pre-Existing Cardiovascular Disease Receiving Oral Androgen Receptor Pathway Inhibitors. Pharmacoepidemiol Drug Saf Asiri IM, Chen RC, Master V, Mi L, James SE, Moore C, Bryce AH, Tilburt JC, Riaz IB, Naqvi SAA, Afzal U, Beach SRH, Cobran EK. PMID: 42322109 [PubMed - indexed for MEDLINE]
	Characteristics of Patients With Advanced or Metastatic Urothelial Cancer Unable to Complete Six Cycles Chemotherapy. Cancer Med Jackson-Spence F, Aspden D, Chauhan V, Diaz S, Graham C, Young M, Nally E, Wells JC, Membribes SC, Ackerman C, Szabados B, Powles T. PMID: 42321602 [PubMed - indexed for MEDLINE]
	A focused systematic review and meta-analysis of robot-assisted inguinal lymphadenectomy versus open inguinal lymph node dissection in penile cancer. J Robot Surg Wen Z, Zhou MG, Wang T, Du P. PMID: 42321563 [PubMed - indexed for MEDLINE]
	Clinical and pathological predictors of early recurrence after neoadjuvant cisplatin gemcitabine in muscle invasive bladder cancer in the RealBLADDER study. Sci Rep Roviello G, Gambale E, Giorgione R, Basso U, Oliveri M, Cremante M, Atzori F, Scagliarini S, Masini C, Baldazzi V, Scolari F, Mela MM, Lai E, Vascotto IA, Rossi V, Calandrelli C, Rossini D, Lavacchi D, Serni S, Minervini A, Pillozzi S, Antonuzzo L. PMID: 42321365 [PubMed - as supplied by publisher]
	Editorial Comment to Real-World Occurrence of Adverse Events Associated With Adjuvant Pembrolizumab Therapy for Renal Cell Carcinoma: A Multicenter Retrospective Study. Int J Urol Tanaka H. PMID: 42321141 [PubMed - in process]
	Prostate Cancer Working Group 4 Recap. Eur Urol Focus Ravi Kumar AS, Hansen AR. PMID: 42321089 [PubMed - as supplied by publisher]
	Association of asymptomatic PSA testing on prostate cancer mortality; a case control study in general practice. BJGP Open Sheikh SR, Castanon A, Mathews C, Round T, Sasieni P. PMID: 42320978 [PubMed - as supplied by publisher]
	Comprehensive genome-wide association study into multiple recurrence and progression risk in non-muscle invasive bladder cancer. Cancer Genet Hof JP, Galesloot TE, Aben KKH, Bryan RT, Catto JWF, Cheng KK, Conroy S, Fleshner NE, van der Heijden AG, James ND, Mengual L, Uunk FM, Verhaegh G, Vrieling A, Zeegers MP, Kiemeney LALM, Vermeulen SH. PMID: 42320430 [PubMed - as supplied by publisher]
	Theranostic strategies in prostate cancer: Advances in PSMA PET imaging and radioligand therapy. Cancer Treat Res Commun Al-Assil T, Han J, Hasan N, Gibson S, Seneriches J, Kim M, Yang J, Srinivas S, Kalebasty AR. PMID: 42320339 [PubMed - as supplied by publisher]
	Predictive value of toll-like receptors, myeloid differentiation factor 88, and nuclear factor kappa-B regarding the response to Bacillus Calmette-Guérin intravesical therapy in patients with high-risk non-muscle-invasive bladder cancer: A controlled cohort clinical study. Urol Oncol Zahran AA, Shokeir AA, Serria MS, Awadalla A, El-Gamal R, Elshabrawy I, Baiomy AA. PMID: 42320108 [PubMed - as supplied by publisher]
	Predicting extraperitoneal ssRARP difficulty: an MRI-based nomogram. J Robot Surg Liu J, Zhang Q, Lin F, Yue G, Huang Y, Zeng B, Cai C, Gu D, Liu Y. PMID: 42319727 [PubMed - indexed for MEDLINE]
	Platelet-Prostate cancer crosstalk driving disparities and therapeutic vulnerabilities. Discov Oncol Mariani V, Lee NH. PMID: 42319679 [PubMed - as supplied by publisher]
	Anatomy and patient comorbidity in robotic partial nephrectomy: predictors of complexity and outcomes. J Robot Surg Pumfrey N, Azhar F, Harwood R, Rahemtoola MS, Zelhof B. PMID: 42319664 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 188782

Page 1 of 9440



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy